New technologies and advancements in hormone therapy, immunotherapy, and targeted therapy are transforming the oncology treatment landscape. Here are some of the important oncology developments and new FDA-approved cancer drugs during 2023.
Emerging respiratory medicines and treatments, including robotic navigation and gene-editing nanoparticles, may significantly improve patient outcomes in the future for prevalent pulmonary diseases like lung cancer, cystic fibrosis, and chronic obstructive pulmonary disease.
Data from the United Network for Organ Sharing shows a 3% increase in organ donation in the US since 2016, and a 27% increase over the last ten years. Whatโs your opinion on new techniques which are helping to facilitate…
What inspired you to specialise in pulmonology and what is the most interesting aspect of working in this area?I did a rotation with a wonderful pulmonologist who became my mentor and made me want to follow in his footsteps.You are…
September will be a very busy month for M3 Global Research! We will be attending two large European medical congresses where we will be spreading the word about our paid studies and the work we do towards improving health and…
| Topic | Methodology | Country | Incentive |
|---|---|---|---|
|
Bladder Cancer |
Online survey 45-min. |
United States/ |
|
|
Breast Cancer |
Online survey 15-min. |
France/ Germany/ Italy/ Spain/ United Kingdom/ United States |
|
|
Evolving Prostate Cancer Treatments |
Online survey 30-min. |
France/ Germany/ United Kingdom/ United States |
|
|
Gastric Cancer |
Online survey 5-min. |
Italy/
|
|
|
Leukaemia |
Online survey 30-min. |
France/ Germany/ Italy/ Spain/ United Kingdom/ United States |
|
|
Malignant Tumour Treatment
|
Online survey 25-min. |
France/ Germany/ Italy/ Spain/ United Kingdom/ United States
|
|
|
Multiple Myeloma |
Online survey 65-min. |
France/ Germany/ Spain/ United Kingdom/
|
|
|
NSCLC Treatments |
Online survey 30-min. |
France/ Germany/ United Kingdom/ United States/
|
*Please note that studies are subject to availability and invites are dependent upon a range of criteria. As such, the studies listed above may not always match the studies available on your dashboard
| Topic | Methodology | Country | Incentive |
|---|---|---|---|
|
Asthma Treatments |
Online survey 30-min. |
Italy/ United Kingdom
|
|
|
Cancer treatment trends |
Online survey 20-min. |
France/ Germany/ United States
|
|
|
Chronic Rhinosinusitis with Nasal Polyps |
Online survey 30-min. |
France/ Germany/ Italy |
|
|
COPD |
Online survey 10-min. |
Germany |
|
|
Interstitial Lung Diseases (ILDs) |
Online survey 60-min. |
United States/
|
|
|
NSCLC [Non Small Cell Lung Cancer] |
Online survey 10-min. |
France/ Germany/ Italy/ Spain |
|
|
Survey on Severe Asthma
|
Online survey 20min. |
Canada/ Germany/ Spain/ France/ United Kingdom/ Italy |
*Please note that studies are subject to availability and invites are dependent upon a range of criteria. As such, the studies listed above may not always match the studies available on your dashboard
